Yes Buckeye. I have been involved in this since 2008 and have played it to the point that if I cashed out now I would do very well. I beleive most of the long timers have played the swings and have reduced thier costs by averaging down, and in doing so have accumulated a good position. I am sure most of us are in this for the potential return on investment, but I have given some thought to the potential increase in the quality of life this epigenitic drug platform will have on the patients. To extend some ones life is something that we are trying to do here and yet we wait for any number patients to pass away so hopefully the rest of us may benifit. I thank the patients for participating in this trial and am greatful for the chance to support it with my investment. I hope we succeed because of the financial benifit for us all and for the benifit of the patients which is priceless.